Crispr Therapeutics Ag
CRSP
$57+2.00 (+3.64%)
Aug 11, 2025, 9:40 AM
Financials
| 52Week High | 71.13 | 52Week Low | 30.04 |
| Beta | 1.83 | Current Ratio Annual | 22.07 |
| Current Ratio Quarterly | 16.61 | Market Cap | 5.00B |
| Net Profit Margin TTM | -1,229.43 | Operating Margin TTM | -1,451.95 |
| Price To Book | 2.92 | Price To Free Cash Flow TTM | 45.88 |
| Price To Sales TTM | 131.47 | Quick Ratio Annual | 21.97 |
| Quick Ratio Quarterly | 16.49 | Return On Assets TTM | -21.52 |
| Return On Equity TTM | -25.25 | Return On Investment TTM | -25.25 |
| Revenue Growth3Y | -65.58 | Revenue Growth5Y | -33.62 |
| Revenue Growth Quarterly Yoy | 72.53 | Revenue Growth TTMYoy | -81.18 |
| Revenue Per Share TTM | 0.44 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 372 | 49 | 68 | 118 | 101 | 99 | 67.98M | $2.12B |
| Jun 30, 2025 | 204 | 36 | 23 | 50 | 41 | 51 | 18.83M | $899.51M |
| Change | 168(45%) | 13(27%) | 45(66%) | 68(58%) | 60(59%) | 48(48%) | 49.15M(72%) | $1.22B(58%) |